This ELISA kit provides quantitative measurement of Spondin-1 (SPON1) in human samples, supporting neuroscience research into this extracellular matrix glycoprotein involved in axon guidance, neuronal development, and emerging roles in Alzheimer's disease pathology. Because SPON1 functions at the intersection of amyloid precursor protein processing and neurodevelopmental signaling, researchers need precise quantification across both circulating and tissue-level compartments.
Detection Range: The 0.312–20 ng/mL range aligns with reported SPON1 concentrations in human plasma and tissue lysates, covering both baseline physiological levels and the elevated expression observed in neurodegenerative contexts. Most serum and plasma samples can be assayed neat or with minimal dilution, simplifying workflow planning.
Sensitivity: At 0.156 ng/mL, the kit detects SPON1 in low-abundance conditions such as cerebrospinal fluid-adjacent fractions, conditioned media from primary neuronal cultures, or samples from early-stage neurodegeneration where subtle expression changes carry biological significance.
Sample Compatibility: Validation across serum, plasma, and tissue homogenates enables researchers to correlate circulating SPON1 levels with localized expression in brain tissue within the same study, bridging biomarker discovery and mechanistic investigation.
Assay Efficiency: The 1–5 hour protocol and 50–100 µL sample volume accommodate limited-volume specimens typical of paired CSF-plasma biobanking studies and primary neuron culture experiments.
This kit is directly applicable to Alzheimer's disease biomarker research, axon guidance pathway studies, and neurodevelopmental disorder investigations.